Searched for
ORBICULAR PHARMACEUTICAL TECHNOLOGIES
Tata Capital Healthcare Fund invests $20 million in Orbicular Pharmaceutical TechnologiesThe specialty generics has a market size of $60 billion and is rapidly expanding, driven by increasing demand for cost-effective alternativ...- Gland Pharma gets USFDA nod for generic breast cancer drugGland Pharma has received approval from the USFDA to market a generic medication for breast cancer treatment, Eribulin Mesylate Injection. ...
- Alembic Pharma buys out partner stake in Aleor DermaceuticalsAleor has product offerings across cream, gel, ointment, shampoo, lotion, solutions, sprays, foams, microsponge and nanoparticulate platfor...
- Alembic Pharma JV Aleor Dermaceuticals gets USFDA nod for testosterone topical solutionAleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application ...
- Alembic Pharma jumps 3% as JV firm completes USFDA inspectionAlembic Pharma manufactures and markets generic pharmaceutical products across the globe.
- Stocks in the news: Gati, Bharti Airtel, Alembic Pharma, Aster DM and DHFLGMR Infra has raised Rs 2,000 crore debt through nonconvertible debentures from Tata Sons.
- Alembic Pharma shares jump over 8% on JV with Orbicular PharmaThe company entered into a joint venture with Orbicular Pharmaceutical to develop, manufacture and commercialise dermatology products for g...
- Alembic-Orbicular Pharma JV to develop, manufacture dermatology products"APL and Orbicular will own 60 per cent and 40 per cent of the equity capital of Aleor when the transaction is completed," the Vadodara-bas...
Load More